News & Articles

The facility will be capable of manufacturing batches ranging from those for early-stage research to GMP for clinical and future commercial uses

This open access tool, powered by data supplied by GISAID, provides virologists and COVID-19 test developers insight to the latest viral variants and primer designs used around the world

Scientific, technological and communications excellence has been celebrated at the Clinical Science Summit, with Beckman Coulter, Zymo Research, and PerkinElmer among those recognized

Watch this on-demand webinar to discover a new approach to profiling antibody responses by quantifying affinity and concentration

The drug candidate was associated with a reduction in the need for supplemental oxygen support, earlier time to discharge from hospital and was well tolerated

Learn about the large scale COVID-19 PCR testing program set up by the government of Luxembourg

Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations

Learn more about the efficient and reproducible multiplex immunoassays set to change the way COVID-19 researchers profile antibody response

The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality

OncoHost’s AI-Based proteomic profiling platform, PROphet, to serve key role in host response evaluation of late-stage disease patients

356-patient concordance study confirms performance using head-to-head testing vs. droplet digital PCR

Top talks presenting the latest technologies, research and applications are now available on demand

Real-world data demonstrated 92% vaccine effectiveness against hospitalisations due to the Delta variant

Infectious disease scientist Dr. Padmapriya Banada explores the potential of cycle threshold values and reveals her melt-based assay alternative

This multi-session event will take you on a weekly path of discovery, featuring the latest in IHC antibodies, histology troubleshooting techniques, case studies in pathology, and more

Novel chip-based diagnostic technology can detect individual viral antigens in nasal swab samples to identify the viruses that cause COVID-19 and flu with a single test